MEK1 antibody (pSer218, pSer221)
Quick Overview for MEK1 antibody (pSer218, pSer221) (ABIN196945)
Target
See all MEK1 (MAP2K1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pSer218, pSer221
-
Specificity
- This antibody detects endogenous levels of MEK1/MEK2 only when phosphorylated at Serine 217/221.
-
Purification
- Affinity Chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
Immunogen
- Peptide sequence around the phosphorylation site of Serine 217/221 (I-D-Sp-M-A) derived from Human MEK1/MEK2
-
-
-
-
Application Notes
-
Immunohistochemistry on Paraffin Sections: 1/50approx. 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, containing 150 mM NaCl and 50 % Glycerol, 0.02 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- MEK1 (MAP2K1) (Mitogen-Activated Protein Kinase Kinase 1 (MAP2K1))
-
Alternative Name
- MAP2K1
-
Background
- Synonyms: Dual specificity mitogen-activated protein kinase kinase 1/2, ERK activator kinase 1, ERK activator kinase 2, MAP kinase kinase 1, MAP kinase kinase 2, MAPK/ERK kinase 1, MAPK/ERK kinase 2, MAPKK1, MEK1, MEK2, PRKMK1, PRKMK2
-
Molecular Weight
- 45 kDa
-
Gene ID
- 5604
-
NCBI Accession
- NP_002746
-
UniProt
- Q02750
-
Pathways
- MAPK Signaling, RTK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, Neurotrophin Signaling Pathway, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagy, Signaling of Hepatocyte Growth Factor Receptor, BCR Signaling
Target
-